{"data":{"id":"us-in/ic-16-41-12-6.5","jurisdiction":"us-in","citation":"IC 16-41-12-6.5","heading":"Human cells, tissues, or cellular or tissue-based products","body":"Sec. 6.5. As used in this chapter, \"human cells, tissues, or cellular or tissue-based products\" or \"HCT/Ps\" has the meaning set forth in 21 CFR 1271.3(d).","path":["TITLE 16. HEALTH","ARTICLE 41. PUBLIC HEALTH MEASURES FOR THE PREVENTION AND CONTROL OF DISEASE","Chapter 12. Communicable Disease: Precautionary Measures for Use of Human Tissues and Blood Products; Regulation of Blood Centers"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-41-12-6.5","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"83c738938b08897138f7f261757c86c8efa6175e7cb05842cc1901c69cb8db15","source_id":"us-in","stale":false,"prev":"us-in/ic-16-41-12-6","next":"us-in/ic-16-41-12-7"},"notice":"GroundRules: Original legal text. Not legal advice."}